M&A - Damadian Timothy Raymond

Add to your watchlist
Back to List of Mergers and Acquisitions

Form Type: SCHEDULE 13D

Filing Date: 2025-07-11

Corporate Action: Acquisition

Type: New

Accession Number: 000173112225000961

Filing Summary: On July 7, 2025, the Reporting Persons, led by Timothy Raymond Damadian, expressed their intent to enter discussions with the Board of Directors of FONAR Corporation regarding a 'going private transaction.' This involves acquiring securities of the Issuer not currently owned by them through a newly formed entity. The group submitted a non-binding proposal letter to the Board, outlining their intentions. The Reporting Persons have accumulated substantial shares of Common Stock, with Damadian holding approximately 1.9% and Jevan Damadian approximately 1.3% of the total acceptable shares. The document also reveals that the Reporting Persons plan to engage in continuous dialogue with relevant parties regarding the Issuer and this potential transaction. Furthermore, various shares have been acquired through personal funds and inheritance, reflecting a mix of personal investment strategies and benefits from the previous leadership of the company.

Additional details:

Reporting Person: Timothy Raymond Damadian

Shares Beneficially Owned: 121553

Percentage Beneficially Owned: 1.9


Reporting Person: Jevan Damadian

Shares Beneficially Owned: 78853

Percentage Beneficially Owned: 1.3


Reporting Person: Luciano Benedetto Bonanni

Shares Beneficially Owned: 47026


Reporting Person: Ronald George Lehman II

Shares Beneficially Owned: 4330


Reporting Person: Richard Alan Feigenbaum

Shares Beneficially Owned: 0


Reporting Person: Xavier Patrick Rodrigo

Shares Beneficially Owned: 37196


Reporting Person: James Joseph Flanagan

Shares Beneficially Owned: 8851


Reporting Person: Kurt William Reimann

Shares Beneficially Owned: 2000


Reporting Person: Janice Veroline

Shares Beneficially Owned: 7697


Reporting Person: James Persoons

Shares Beneficially Owned: 0


Comments

No comments yet. Be the first to comment!